Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biofizika ; 52(6): 1120-7, 2007.
Artigo em Russo | MEDLINE | ID: mdl-18225665

RESUMO

Lucigenin-enhanced chemiluminescence (LcCL) allows one to investigate the reactions of superoxide anion radical (*O2-) generated by mitochondria and is applied to study the superoxide production in enzymatic and membrane systems by isolated mitochondria and cells, and in whole organs. The application of lucigenin-enhanced chemiluminescence to estimate the respiration of human tissues involves the use of small tissue pieces, which can be obtained, for instance, by biopsia; however, no systematic investigations have been performed on these objects. In the present paper, a comparative study of lucigenin-enhanced chemiluminescence of tissues isolated from different organs of the rat was carried out to elucidate its dependence on the extent of tissue defragmentation, storage time, and access for oxygen. It was shown that the addition of lucigenin to a piece of tissue, a suspension of fine tissue fragments, and homogenates greatly enhanced chemiluminescence, and a whole piece of tissue possessed a much lesser (by 1-1.5 order of magnitude) intensity of chemiluminescence than homogenate or gruel. In the absence of stirring of the surrounding solution, the lucigenin-enhanced chemiluminescence of tissue quickly decreased, apparently due to a decrease in the level of oxygen in the tissue, as the result of its consumption. The chemiluminescence consisted of two components: a lucigenin-dependent and lucigenin-independent one (intrinsic chemiluminescence). Thus, the tissue was a source of lucigenin-enhanced chemiluminescence, and this luminescence was observed only at a sufficient access for oxygen. The lucigenin-independent component did not practically depend on oxygen and was determined by the components coming out of the tissue into the surrounding solution. Nitric oxide (NO) inhibited chemiluminescence as its concentration increased and did not affect considerably the rate of oxygen consumption by the tissue. The results obtained allow one to conclude that lucigenin can be used as a rather effective chemiluminescent probe for the production of superoxide radicals by tissue pieces.


Assuntos
Acridinas/metabolismo , Substâncias Luminescentes/metabolismo , Oxigênio/metabolismo , Acridinas/farmacologia , Animais , Encéfalo/metabolismo , Humanos , Cinética , Fígado/metabolismo , Luminescência , Substâncias Luminescentes/farmacologia , Medições Luminescentes , Masculino , Óxido Nítrico/metabolismo , Especificidade de Órgãos , Ratos , Baço/metabolismo , Superóxidos/metabolismo
2.
Biomed Khim ; 52(1): 69-82, 2006.
Artigo em Russo | MEDLINE | ID: mdl-16739923

RESUMO

Antioxidant activity (AA) of inhibitors of free radical reactions (FRR) (dieton, mexidol, trypsin), aplied to the dressing material for wound healing was studied. In our work we used a model system containing suspension of laminated liposome, formed from fraction of total chicken yolk phospholipids. Lipid peroxidation (LPO) of liposome membranes was initiated by addition of Fe2+ ions. The kinetics of FRR was followed by coumarine-enhanced chemiluminescence (CL). It was found that AA of the inhibitors was determined by their ability to intersept aqueous and hydrofobic free radicals and chelate Fe2+ ions. Their ability to intersept radicals reduced in the following order: dieton > trypsin > mexidol. In addition we discovered unknown ability of mexidol to interact with Fe2+, that resulted in elemination of FRR catalyst. Investigating AA of the FRR inhibitors in the two-components mixture, consisting of dieton and mexidol, we observed the effect of multifunctionality: dieton, increased the duration of latent period of CL by intersepting lipid peroxyl radicals, while mexidol, decreased its value by interacting with Fe2+, i.e. mexidol masked the action of dieton. Investigating AA of two-components mixture, consisting of mexidol and trypsine, we observed the same effect of multifunctionality. In the two-component mixture, consisting of trypsine and dieton, the action of the inhibitors was found to be synergistic. All antioxidant properties of these FRR inhibitors were also preserved in the three component mixture. Hence, mixture components, dieton, mexidol and trypsin, possess high AA, that validates their use in dressing materials employed for wound healing.


Assuntos
Antioxidantes/química , Bandagens , Cicatrização , Cátions Bivalentes , Dicarbetoxi-Di-Hidrocolidina/análogos & derivados , Dicarbetoxi-Di-Hidrocolidina/química , Sinergismo Farmacológico , Radicais Livres/antagonistas & inibidores , Radicais Livres/química , Ferro/química , Peroxidação de Lipídeos , Lipossomos , Medições Luminescentes , Oxirredução , Fosfolipídeos/química , Picolinas/química , Tripsina/química
3.
Vestn Oftalmol ; 120(4): 14-8, 2004.
Artigo em Russo | MEDLINE | ID: mdl-15384840

RESUMO

Parameters of lipid peroxidation (LP) and antioxidant activity (AOA) of tear and blood plasma were examined in 22 healthy subjects (44 eyes) as well as in 33 patients with peripheral vitreochoreoretinal dystrophies (PVCRD--60 eyes), in 32 patients with non-operated dystrophic retinal detachment (DRD--34 eyes) and in 135 patients with operated retinal detachment, stable visual functions and with the postoperative period ranging from 4 months to 10 years (137 eyes). The results denoted a lower tear AOA (on the average by 35%) in patients with DRD and PVCRD, whereas, the blood plasma AOA or LP products' content remained unchanged. It is indicative of a local nature of metabolic impairments, specifically, of impairments in the system of antioxidant protection of the eye. Flavonoid antioxidants (dikvertin and ginkgo biloba) reduced the content of LP products, and induced the AOA in tear and blood plasma in patients with PVCRD and retinal detachment; they also improved the visual functions in patients with operated retinal detachment. Therefore, the flavonoid antioxidants can be recommended for adding to the complex treatment of PVCRD and DRD for the purpose of improving and stabilizing the visual functions and for neuroprotection.


Assuntos
Antioxidantes/uso terapêutico , Doenças da Coroide/tratamento farmacológico , Flavonoides/uso terapêutico , Degeneração Retiniana/tratamento farmacológico , Descolamento Retiniano/tratamento farmacológico , Corpo Vítreo , Administração Oral , Adolescente , Adulto , Idoso , Antioxidantes/administração & dosagem , Doenças da Coroide/metabolismo , Flavonoides/administração & dosagem , Seguimentos , Ginkgo biloba , Humanos , Peroxidação de Lipídeos , Pessoa de Meia-Idade , Fitoterapia , Quercetina , Degeneração Retiniana/metabolismo , Descolamento Retiniano/metabolismo , Descolamento Retiniano/cirurgia , Fatores de Tempo
4.
Ross Fiziol Zh Im I M Sechenova ; 89(12): 1516-22, 2003 Dec.
Artigo em Russo | MEDLINE | ID: mdl-14870489

RESUMO

A deficiency of tetrahydrobiopterin (BH4), a NO-synthase co-factor, results in reactive oxygen species synthesis by NO-synthase. It leads to disturbances of endothelium-dependent vasorelaxation. We performed our study on the monocrotaline model of pulmonary hypertension. A decrease in endothelium-dependent relaxation was observed only in intrapulmonary arteries of monocrotaline-treated rats. A perfusion of BH4 (0.1 mol/liter) increased significantly endothelium-dependent dilation of hypertensive pulmonary arteries (p < 0.01). But BH4 did not influence the relaxation of systemic vessels and the dilation responses of pulmonary and systemic arteries of control rats. Measuring of superoxide by lucigenin-mediated chemiluminescence showed five-fold O2- production in intrapulmonary arteries of pulmonary hypertensive rats, that was activated by acetylcholine and inhibited by a nonselective NO-synthase blocker (L-NAME). However, activity of NO-synthase measured as [H3]arginine to [H3]citrulline conversion and assessed in pulmonary vessels and aortic tissue, did not differ in control and monocrotaline-treated groups. These data suggest, that there is a local deficiency of BH4--in pulmonary vessels, without significant changes of systemic circulation.


Assuntos
Biopterinas/análogos & derivados , Biopterinas/metabolismo , Endotélio Vascular , Hipertensão Pulmonar/fisiopatologia , Pulmão , Artéria Pulmonar , Vasodilatação/fisiologia , Animais , Biopterinas/farmacologia , Modelos Animais de Doenças , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/metabolismo , Hipertensão Pulmonar/induzido quimicamente , Hipertensão Pulmonar/metabolismo , Pulmão/irrigação sanguínea , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Masculino , Monocrotalina/toxicidade , Óxido Nítrico Sintase/metabolismo , Oxigênio/metabolismo , Artéria Pulmonar/efeitos dos fármacos , Artéria Pulmonar/metabolismo , Ratos , Ratos Wistar , Vasoconstritores/farmacologia , Vasodilatação/efeitos dos fármacos , Vasodilatadores/farmacologia
5.
Vopr Med Khim ; 47(3): 288-300, 2001.
Artigo em Russo | MEDLINE | ID: mdl-11558311

RESUMO

Using three chemiluminescent model systems of oxidation (suspension of phospholipid liposomes, a geous solution of haemoglobin-hydrogen peroxide-luminol and a geous solution 2,2'-azo-bis-(2-methylpropionamidine)dihydrochloride-luminol) the antioxidant activity and mechanism of antioxidant action of three 3-oxypyridine analogues: (mexidol, emoxipin and proxipin) were studied. These compounds were shown: a) to interact with catalitically active two valency iron ions (Fe2+), that causes elimination of ions from the model system; b) to scavenge reactive oxygen species and/or luminol radicals produced in the model systems. Their activity reduced in the following order: mexidol > emoxipin > proxipin. The antioxidant activity of 3-oxypyridines may underline known clinical effects of these compounds.


Assuntos
Antioxidantes/metabolismo , Picolinas/metabolismo , Piridinas/metabolismo , Antioxidantes/química , Ferro/metabolismo , Peroxidação de Lipídeos , Picolinas/química , Piridinas/química , Espécies Reativas de Oxigênio
6.
Vopr Med Khim ; 45(4): 326-31, 1999.
Artigo em Russo | MEDLINE | ID: mdl-10547883

RESUMO

The effect of arbidol and its structural analogues on the process of lipid peroxidation in phospholipid liposomes induced by Fe2+ has been investigated. It was shown that the antioxidant efficacy of arbidol and its derivatives is lower than that of alpha-tocopherol by two or three times. It was suggested that the mechanism antioxidant action of the arbidol and its structural analogues consists of scavenging of lipid radicals rather than chelating of Fe2+.


Assuntos
Antioxidantes/farmacologia , Indóis/farmacologia , Sequestradores de Radicais Livres/farmacologia , Cinética , Peroxidação de Lipídeos/efeitos dos fármacos , Medições Luminescentes , Fosfolipídeos/metabolismo , Vitamina E/farmacologia
7.
Vestn Ross Akad Med Nauk ; (2): 15-22, 1999.
Artigo em Russo | MEDLINE | ID: mdl-10204018

RESUMO

Model systems used in the determination of serum antioxidative activity (AOA), which differ both in the way of generating free radicals and in the mode of their detection, are clinically analyzed. The specific features and potentialities of the model systems developed at the authors' laboratory are characterized. These included yolk lipoprotein suspensions, liposomal suspensions formed from total phospholipid fraction, the hemoglobin-hydrogen peroxide-luminol system. The investigations show that most model systems for determining serum AOA contribute to the water soluble interceptors of free radicals (ascorbate, urate, plasma proteins, etc.), chelating and oxidative agents of catalytically active Fe2+ (ceruloplasmin, transferrin, albumin, etc.). The serum AOA levels measured with different model systems vary with the body's status. To determine serum AOA and the contribution of major endogenous antioxidants and inhibitors of free radical reactions may be a basis for the goal-oriented use of exogenous antioxidants in the therapy of a great variety of diseases.


Assuntos
Antioxidantes/metabolismo , Peroxidação de Lipídeos/fisiologia , Plasma/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Animais , Humanos , Recém-Nascido , Oxirredução
9.
Vopr Med Khim ; 44(1): 70-6, 1998.
Artigo em Russo | MEDLINE | ID: mdl-9575615

RESUMO

The method of valuation of the blood plasma antioxidant activity (AOA) by the hemoglobin-hydrogen peroxide-luminol chemiluminescence system has been proposed. The method is based on the measuring the induction time of chemiluminescence that is directly proportional to the added volume of plasma or concentration of standard antioxidant. The ascorbate was taken as a standard. Blood plasma AOA has been expressed through the concentration of equivalent ascorbate solution (ascorbate equivalent). The influence of hemolysis and storage conditions of plasma on its detected AOA was investigated. The change of human blood plasma AOA after single administration of 2 g the ascorbate and its dynamics in patients with acute pancreatitis was studied.


Assuntos
Antioxidantes/análise , Luminol , Pancreatite/sangue , Doença Aguda , Adulto , Ácido Ascórbico/administração & dosagem , Radicais Livres , Hemoglobinas/análise , Humanos , Peróxido de Hidrogênio/análise , Medições Luminescentes , Masculino , Pessoa de Meia-Idade , Oxirredução
10.
Vopr Med Khim ; 44(6): 565-70, 1998.
Artigo em Russo | MEDLINE | ID: mdl-10599143

RESUMO

The changes of lipid peroxidation parameters and state of blood serum antioxidant system in acute destructive pancreatitis were investigated. The increased content of blood serum diene conjugates and thiobarbituric acid reactive substances was found. It was shown that the blood serum antioxidant activity had correlated with concentration of urate (r = +0.79, p < 0.001).


Assuntos
Antioxidantes/metabolismo , Peróxidos Lipídicos/sangue , Pancreatite Necrosante Aguda/sangue , Adulto , Idoso , Feminino , Radicais Livres , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...